Cytek Biosciences logo

Cytek Biosciences Share Price Today

(NASDAQ: CTKB)

Cytek Biosciences share price is $4.47 & ₹389.18 as on 6 Mar 2025, 2.30 'hrs' IST

$4.47

0.16

(3.71%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cytek Biosciences share price in Dollar and Rupees. Guide to invest in Cytek Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cytek Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Cytek Biosciences share price movements

  • Today's Low: $4.28
    Today's High: $4.51

    Day's Volatility :5.1%

  • 52 Weeks Low: $4.20
    52 Weeks High: $8.18

    52 Weeks Volatility :48.62%

Cytek Biosciences (CTKB) Returns

PeriodCytek Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-31.65%
3.7%
0.0%
6 Months
-17.83%
-2.8%
0.0%
1 Year
-36.78%
2.5%
0.0%
3 Years
-63.6%
12.9%
-11.6%

Cytek Biosciences (CTKB) Key Statistics

in dollars & INR

Previous Close
$4.31
Open
$4.3
Today's High
$4.51
Today's Low
$4.28
Market Capitalization
$552.1M
Today's Volume
$846.7K
52 Week High
$8.175
52 Week Low
$4.2
Revenue TTM
$200.5M
EBITDA
$-15.9M
Earnings Per Share (EPS)
$-0.05
Profit Margin
-3.0%
Quarterly Earnings Growth YOY
0.74%
Return On Equity TTM
-1.53%

How to invest in Cytek Biosciences Stock (CTKB) from India?

It is very easy for Indian residents to invest directly in Cytek Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cytek Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cytek Biosciences or CTKB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cytek Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cytek Biosciences shares which would translate to 0.195 fractional shares of Cytek Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cytek Biosciences, in just a few clicks!

Returns in Cytek Biosciences (CTKB) for Indian investors in Rupees

The Cytek Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cytek Biosciences investment value today

Current value as on today

₹68,290

Returns

₹31,710

(-31.71%)

Returns from Cytek Biosciences Stock

₹36,775 (-36.78%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Cytek Biosciences (CTKB)

38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cytek Biosciences Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cytek Biosciences

  • BlackRock Inc

    14.43%

  • Vanguard Group Inc

    9.15%

  • Brown Capital Management, LLC

    6.44%

  • Hillhouse Capital Advisors, Ltd.

    5.20%

  • State Street Corp

    3.52%

  • Geode Capital Management, LLC

    2.06%

Analyst Recommendation on Cytek Biosciences

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Cytek Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Cytek Biosciences Stock (CTKB)

What analysts predicted

Upside of 60.79%

Target:

$7.19

Current:

$4.47

Insights on Cytek Biosciences Stock (Ticker Symbol: CTKB)

  • Price Movement

    In the last 7 days, CTKB stock has moved down by -7.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 51.5M → 33.65M (in $), with an average decrease of 34.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -10.43M → 9.64M (in $), with an average increase of 649.5% per quarter
  • CTKB vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 92.1%
  • CTKB vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 205.0%
  • Price to Sales

    ForCTKB every $1 of sales, investors are willing to pay $2.9, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

Cytek Biosciences Technicals Summary

Sell

Neutral

Buy

Cytek Biosciences is currently in a neutral trading position according to technical analysis indicators.

Cytek Biosciences (CTKB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cytek Biosciences Inc logo
-17.53%
-17.83%
-36.78%
-63.6%
-76.17%
Medtronic Plc logo
3.4%
5.22%
9.95%
-11.8%
1.8%
Edwards Lifesciences Corp. logo
2.13%
10.35%
-17.53%
-32.76%
14.39%
Boston Scientific Corp. logo
1.13%
28.68%
55.31%
146.09%
207.16%
Stryker Corporation logo
0.84%
10.53%
11.46%
56.15%
129.21%
Abbott Laboratories logo
6.67%
21.76%
15.39%
15.86%
78.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cytek Biosciences Inc logo
351.5
NA
NA
0.12
-0.02
-0.03
NA
3.06
Medtronic Plc logo
28.71
28.71
1.91
5.45
0.08
0.05
0.03
38.49
Edwards Lifesciences Corp. logo
31.13
31.13
5.57
2.45
0.17
0.08
NA
16.99
Boston Scientific Corp. logo
84.24
84.24
1.87
2.86
0.09
0.05
NA
14.76
Stryker Corporation logo
50.77
50.77
2.91
13.49
0.15
0.07
0.01
54.1
Abbott Laboratories logo
18.34
18.34
2.52
5.15
0.31
0.06
0.02
27.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cytek Biosciences Inc logo
Buy
$552.1M
-76.17%
351.5
-3.0%
Medtronic Plc logo
Buy
$119.3B
1.8%
28.71
12.83%
Edwards Lifesciences Corp. logo
Buy
$42.8B
14.39%
31.13
76.75%
Boston Scientific Corp. logo
Buy
$152.9B
207.16%
84.24
11.07%
Stryker Corporation logo
Buy
$148.8B
129.21%
50.77
13.25%
Abbott Laboratories logo
Buy
$238.6B
78.8%
18.34
31.95%

About Cytek Biosciences

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Organization
Cytek Biosciences
Employees
0
CEO
Dr. Wenbin Jiang Ph.D.
Industry
Healthcare

Management People of Cytek Biosciences

NameTitle
Dr. Wenbin Jiang Ph.D.
President, CEO & Chairman of the Board
Dr. Ming Yan Ph.D.
CTO & Director
Ms. Valerie T. Barnett J.D.
Chief Legal Officer & Corporate Secretary
Dr. Allen B. Poirson Ph.D.
Senior Vice President of Business & Corporate Development
Mr. Patrik Sebastian Jeanmonod
Head of Corporate Development Analytics
Mr. William D. McCombe
Chief Financial Officer
Dr. Philippe Busque Ph.D.
Senior Vice President of Global Sales & Services

Important FAQs about investing in CTKB Stock from India :

What is Cytek Biosciences share price today?

Cytek Biosciences share price today stands at $4.47, Open: $4.30 ; Previous Close: $4.31 ; High: $4.51 ; Low: $4.28 ; 52 Week High: $8.18 ; 52 Week Low: $4.20.

The stock opens at $4.30, after a previous close of $4.31. The stock reached a daily high of $4.51 and a low of $4.28, with a 52-week high of $8.18 and a 52-week low of $4.20.

Can Indians buy Cytek Biosciences shares?

Yes, Indians can invest in the Cytek Biosciences (CTKB) from India.

With INDmoney, you can buy Cytek Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cytek Biosciences at zero transaction cost.

How can I buy Cytek Biosciences shares from India?

It is very easy to buy Cytek Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cytek Biosciences (CTKB) be purchased?

Yes, you can buy fractional shares of Cytek Biosciences with INDmoney app.

What are the documents required to start investing in Cytek Biosciences stocks?

To start investing in Cytek Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cytek Biosciences Stock (CTKB)?

Today’s highest price of Cytek Biosciences (CTKB) is $4.51.

Today’s lowest price of Cytek Biosciences (CTKB) is $4.28.

What is today's market capitalisation of Cytek Biosciences?

Today's market capitalisation of Cytek Biosciences CTKB is 552.1M

What is the 52 Week High and Low Range of Cytek Biosciences Stock (CTKB)?

  • 52 Week High

    $8.18

  • 52 Week Low

    $4.20

What are the historical returns of Cytek Biosciences (CTKB)?

  • 1 Month Returns

    -17.53%

  • 3 Months Returns

    -17.83%

  • 1 Year Returns

    -36.78%

  • 5 Years Returns

    -76.17%

Who is the Chief Executive Officer (CEO) of Cytek Biosciences ?

Dr. Wenbin Jiang Ph.D. is the current Chief Executive Officer (CEO) of Cytek Biosciences.

Discover More